Claudio Punzo, PhD; Johanna Seddon, MD, ScM; and Shun-Yun Cheng, PhD’22, are receiving awards from the American Macular Degeneration Foundation.

Eviatar Yemini, PhD, was chosen to receive a seed grant from the Hypothesis Fund, an innovative, new nonprofit that relies on a network of scientist “scouts” to identify and recommend novel, early-stage research to fund.

Kavita Babu, MD, was a co-author of a recent study from the National Highway Traffic Safety Administration on toxicological analyses of blood specimens from roadway users who were seriously or fatally injured in motor vehicle crashes.

The goal of research by Susan Swain, PhD, is to ultimately provide a blueprint for a vaccine that would recognize evolving influenza strains and provide long-lasting immunity to people throughout the life cycle, particularly among older adults, whose immune responses become weaker as they age.

UMass Chan Medical School has licensed the rights to develop and commercialize a novel second-generation gene therapy to treat spinal muscular atrophy developed by Jun Xie, PhD, Guangping Gao, PhD, and colleagues to global biopharmaceutical company CANbridge Pharmaceuticals Inc.

UMass Chan Medical School will evaluate the NIH’s new Home Test to Treat program that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities across the country.